Evidence map›Paper›PMID 22212229›Full record

ReviewClinical and translational science2011

Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.

Jessica Wen

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and translational science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Macroscopic hematuria in a child with portal hypertension: Answers.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. [Congenital hepatic fibrosis with polycystic kidney diseases: case report].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2015
    Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jessica WenDivision of Gastroenterology, Hepatology & Nutrition, The Children's Hospital of Philadelphia, Pennsylvania, USA. wenj@email.chop.edu
Children's Hospital of Philadelphia · US

Funding

Mechanism of Liver Fibrosis and TGF-beta Signaling in Congenital Hepatic FibrosisF32DK083213 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI WEN, JESSICA WEI-YUN · 2008 to 2010
$109k
NIDDK NIH HHS F32 DK083213
6 · The paper itself

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a developmental disorder that mainly affects the kidneys and the biliary tract. Affected patients often have massively enlarged cystic kidneys as well as congenital hepatic fibrosis (CHF) characterized by dilated bile ducts and associated peribiliary fibrosis. This review will examine what is known about ARPKD-associated liver disease and will highlight areas of ongoing research into its pathogenesis and potential treatment.

Indexed as

AnimalsCalciumCaroli DiseaseCyclic AMPDisease Models, AnimalExonsHumansLiverLiver CirrhosisMicePolycystic Kidney, Autosomal RecessiveRatsRats, Sprague-DawleyTranslational Research, BiomedicalCalciumCyclic AMP

Identifiers

PMID22212229
PMCPMC3252199
OpenAlexW2047477746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.